Related Experiment Video

Updated: Jul 13, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Estrogen receptor-beta: why may it influence clinical outcome in estrogen receptor-alpha positive breast cancer?

Margaret A Shupnik

    Breast Cancer Research : BCR
    |July 10, 2007
    PubMed

    Insights

    Estrogen receptor beta (ER-beta) antagonizes cell cycle genes in ER-alpha-positive breast cancer. Higher ER-beta levels in tumors correlate with better outcomes, suggesting ER-beta as a positive diagnostic marker.

    Area of Science:

    • Endocrinology
    • Oncology
    • Molecular Biology

    Background:

    • Estrogen receptor (ER)-alpha and ER-beta play distinct roles in breast cancer.
    • ER-alpha signaling drives proliferation in many breast cancers.
    • The specific function of ER-beta in ER-alpha-positive breast cancer requires further elucidation.

    Discussion:

    • Lin et al. demonstrate ER-beta's antagonistic effect on ER-alpha/estrogen-stimulated genes.
    • These targeted genes are crucial for cell cycle regulation and DNA replication.
    • This antagonism suggests a tumor-suppressive role for ER-beta in this context.

    Key Insights:

    • Increased ER-beta expression in ER-alpha-positive breast cancer cells inhibits key proliferative genes.
    • Tumors with higher ER-beta levels exhibit similar gene expression patterns.
    • This molecular finding correlates with improved clinical outcomes in patients.

    Outlook:

    • ER-beta may serve as a predictive biomarker for therapeutic response.
    • Targeting ER-beta could offer novel therapeutic strategies for breast cancer.
    • Further research should validate ER-beta's role in diverse breast cancer subtypes.

    More Related Videos

    Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

    Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

    Published on: March 17, 2016

    Related Concept Videos

    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    Transducer Mechanism: Nuclear Receptors01:31

    Transducer Mechanism: Nuclear Receptors

    Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
    About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    Adrenergic Receptors: β Subtype01:26

    Adrenergic Receptors: β Subtype

    β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
    Isoprenaline > Adrenaline > Noradrenaline
    Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
    β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
    Target Cell Response to Hormones01:22

    Target Cell Response to Hormones

    Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
    Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

    Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
    Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...